Welcome! This blog contains research & information on lifestyle, nutrition and health for those with MS, as well as continuing information on the understanding of the endothelium and heart-brain connection. This blog is informative only--all medical decisions should be discussed with your own physicians.

The posts are searchable---simply type in your topic of interest in the search box at the top left.

Almost all of MS research is initiated and funded by pharmaceutical companies. This maintains the EAE mouse model and the auto-immune paradigm of MS, and continues the 20 billion dollar a year MS treatment industry. But as we learn more about slowed blood flow, gray matter atrophy, and environmental links to MS progression and disability--all things the current drugs do not address--we're discovering more about how to help those with MS.

To learn how this journey began, read my first post from August, 2009. Be well! Joan

Thursday, June 20, 2013

Photorelaxation, UV rays and CCSVI




June 20, 2013

Dr. Richard Weller of Edinburgh University reports on research finding that when skin is exposed to UV rays for 20 minutes, vasodilating nitric oxide is released.  This effect is independent of vitamin D levels--and may explain why even if D levels are raised by supplementation, the full benefit is not received.  

Why does this matter to those with CCSVI and MS?
If MS is a disease of hypoperfusion (or slowed blood and CSF flow thru the brain)-- looking at all of the environmental issues which may compound this problem is essential.  An improvement in endothelial health and nitric oxide utilization can help in symptom relief.
Here's more on how the research connects MS and UV rays--

MS and latitude--

There is a significant link between MS and the amount of sunshine we receive.  The connection of higher MS prevalence for those living in northern latitudes has been long-established---based on 30 years of research.   

This explains why Canada, Ireland and Scotland have higher rates of MS than countries nearer the equator.
(NOTE-This does not mean living at a northern latitude causes MS.   It means there is an environmental link which has been scientifically noted regarding northern latitudes and the prevalence of MS diagnoses.)

There has been a recent surge in published research on the connection of Multiple Sclerosis and UV rays, in relation to vitamin D.  The connection is being further elucidated every day.   Dr. Embry's Direct-MS has the most complete library of full research papers available online.  Here is a link for those who wish to explore Vitamin D more thoroughly:

But UV rays may have an effect on MS, outside of the production of vitamin D.

+++++++++++++++++++++

Dr. Furchgott and the Discovery of Photorelaxation
In reading up on the effect of UV rays on the body, and I came back to the research of Nobel prize winning researcher, Dr. Robert F. Furchgott.  He passed away in 2009, and his university keeps his web page online.  Dr. Furchgott was a professor at SUNY Downstate in Brooklyn, NY---the same place where Dr. Sal Sclafani recently retired and where the first CCSVI conference was held in the US!   Here's Dr. Furchgott's page--

Dr. Furchgott discovered the process of photorelaxation over 40 years ago.  What he noted in the lab was that exposure to UV rays changed the endothelium, encouraging nitric oxide production and vasodilation of arteries.   In 2009, before he passed, he stated the current working hypothesis-- 
The present working hypothesis is that light photoactivates some material in the vascular smooth muscle, causing the release of some product which stimulates the guanylyl cyclase to produce cGMP. We are planning experiments to test this hypothesis. One possibility is that the vascular smooth muscle in vivo accumulates some "end pro" formed from the endothelium-derived nitric oxide, and that this product releases NO intracellularly when exposed to the proper wavelengths of light.

Friday, May 24, 2013

History, Hysteria and Hope


May 24, 2013
  
In the last two years, the paradigm for treating MS has changed.  Vitamin D supplementation is routinely recommended.  A healthy diet and exercise are encouraged.  Stress reduction and lifestyle changes, like smoking cessation, are encouraged.  

We are seeing a subtle shift in the understanding of MS as a purely autoimmune disease which cannot be modified, to an inflammatory disease which can be addressed with lifestyle changes encouraging cardiovascular health.

This is new.  

We also now understand that the changes which happen to the brain early in the MS disease process create pain, depression and fatigue.  These are not imagined symptoms.  They are real, and linked to atrophy of the hippocampus and thalamus.

Here is some more background about how MS has been viewed and treated throughout history.
You will see, the shift in how neurology considers MS is still evolving.
We're getting there.

The history of MS research is full of assumptions that were once held as fact by neurologists, but were later proven untrue.  It's important to review how multiple sclerosis patients have been described over the course of history, in order to understand the current mindset of neurology.  I hope this opens some eyes.   

Each of these three points were once believed to be factual.  We now know they were wrong, dead wrong. 
But the repercussions of these inaccurate beliefs linger today.

1. MS is related to the patient's psychological condition.

The very beginnings of MS research were dominated by French neurologist Charcot's fascination with hysteria and personality disorders as related to neurological disease.

Hysteria, from the ancient Greek word for uterus, was a nervous illness long associated exclusively with women. Symptoms differed from patient to patient and from one historical period to another, but they always involved both the body and the mind. Some characteristic symptoms included shortness of breath, heaviness in the abdomen, muscular spasms and fainting. Anxiety, irritability and embarrassing or unusual behaviour were also noted.

Hysteria received intense attention during the late 1800s. The French neurologist Jean-Martin Charcot proposed hysteria was an inherited nerve disease, similar to multiple sclerosis...Charcot investigated hysteria using hypnosis. In lectures he invoked characteristic symptoms in male and female hysterics by applying pressure to specific spots on the hypnotised patient’s body. Critics argued these performances testified to Charcot’s powerful influence over his patients, not the nature of hysteria.

This subtle message, which began as an understanding of MS as a disease involving the psyche,  was that MS was somehow initiated by a personality or nervous disorder which could be controlled by the neurologist.  This subtext continued on into the 20th century.  Here is research from the 1950s.

"The personality characteristics associated with multiple sclerosis as revealed by the MMPI profiles are presented and discussed. The personality characteristics revealed are: a reaction of depression, preoccupation and concern about bodily functions, feelings of hopelessness and insecurity, as well as tendencies toward indecisiveness, narrowness of interests, and introversion. Difficulty in accepting the disease, and its progressive limitations, as well as ambivalence and insecurity concerning the future, are often reflected in relatively poor emotional control and social adjustment."

2. MS does not cause fatigue.  

In the 20th century it was believed that fatigue was not a symptom of MS.  It was believed that fatigue was what caused MS.

Patients were told to stop exercising and to rest in order to avoid relapses.  The underlying message, again, was that there was a personality type that developed MS--neurotic, stressful, type A personality--hysterics. The message was that if patients could just rest, take it easy, not worry;  they could avoid relapses and disease progression.  This has been proven untrue.  Many different people develop MS: from athletes to academics, from mothers to rock stars, from children to middle aged adults.   And stress and rest are not part of the equation in contracting the disease.  And fatigue is often the presenting symptom before an official MS diagnosis as we learned this week.  And those who are able to exercise do better with symptom management.

3. MS does not cause pain

 When most people think of multiple sclerosis, they think of a disease that causes symptoms of weakness and motor problems -- not pain.
"About 10 or 20 years ago, there was a saying that MS causes all kinds of trouble but doesn't cause pain, which really isn't true," says Francois Bethoux, MD, director of rehabilitation services at the Mellen Center for Multiple Sclerosis Treatment and Research at The Cleveland Clinic.

As many with MS can tell you---they feel pain.  Their pain is real, and it is caused by their MS.  Even though patients have been describing their pain to their doctors for over a hundred years, it is only in the last 10 years that this has been taken seriously.
__________________________________________________________

I believe that the distance between the multiple sclerosis patient and the neurologist was allowed to persist through the historical characterization of the MS patient as hysteric, emotionally labile, neurotic or mentally unbalanced.  These false depictions were created by a group of doctors who were threatened by their own personal lack of understanding of the disease and inability to change its course.    It was too difficult to confront the ravages of MS and not be able to cure the disease.  It was easier to portray the patient as defective and the source of their malady.   This provided a comfortable distance between doctor and patient.

Neurology so distanced itself from the patient, that THEY DIDN'T EVEN BELIEVE THE MS PATIENT WAS IN ACTUAL PAIN.  It took over one hundred years for neurologists to admit that there might be pain, or fatigue, or depression caused by multiple sclerosis.  This is absurd.

Since the advent of MRI technology, doctors have concrete evidence of the degredation of gray matter, atrophy of the hippocampus, and demyelination in areas of the brain responsible for emotion, pain and cognition.  All of these changes to the brain are linked to depression, pain and fatigue.  
http://ccsviinms.blogspot.com/2010/07/study-on-brain-changes-in-ms-and.html

These changes to the brain occur early in MS.  Researchers can see the slowed blood flow and hypoperfusion.  They can study fMRI images. 7Tesla imaging (Ge, et al) has allowed researchers to see the microscopic vascular changes that happen to the veins in the MS brain. 
http://ccsviinms.blogspot.com/2009/12/hypoperfusion-decreased-blood-flow-in.html

The physical changes to the brain are caused by a disease process.  They are not psychological or imagined.   The disease comes first, and the brain damage follows.

If there are any young neurologists reading this, I implore you, bridge the gap between patient and doctor.
Look at your patients as family members, friends, siblings, loved ones, human beings. 
Study their MRI images, work with vascular doctors and look at their cerebral blood flow, specifically, the venous return.  Don't be afraid of collaboration between disciplines.  For this is the future of medicine.

Talk to your patients, but most importantly, listen to them.  When they tell you they are in pain, or exhausted or depressed--believe them.  Try to help them.  And try to learn WHY this is happening.

It's time to say goodbye to the era of Charcot and hysteria.  It's time for science.
Joan


Charcot demonstrating hypnosis on an "hysterical" Salpêtrière patient, "Blanche" 
A painting by Pierre Brouillet

Wednesday, April 17, 2013

A simple question for BNAC


April 17, 2013 at 12:22pm

I have a very simple question for BNAC-- and the researchers, patient advocates, participants and supporters of the PREMiSe trial.

Why did you report on patient results of Phase 2 when, by your own admission, you didn't improve CCSVI, your endpoint was not met, and the venoplasty treatment was a failure? 

• In phase 2, improvement was observed also in treatment (p=0.02) and sham (p=0.04) arms at month 1 but did not reach >75% restoration of the venous outflow compared to baseline. No differences in VHISS improvement (Venous Hemodynamic insuffiency Severity Score) were detected between phase 2 treated and sham groups (p=0.894).

Here is the full poster, which shows that Phase 2 did NOT reach the end point of venous restoration.  Note, there has never been a published paper in a journal, just this poster.

If you did not correct CCSVI, and the venous insufficiency score of the treated patients was the same as those who were not treated, how can you use any of the phase 2 data?  

Doesn't that mean your venoplasty treatment was a failure?  

++++++++++++++++++++++++++++++++++

How can you report on any of the EDSS data, relapse data, or new lesions data if the treatment did not correct CCSVI?

According to your study outline, the end point for venoplasty "success" was  >75% restoration of the venous outflow compared to baseline. 

And you achieved this in the unblinded phase 1 part of the study!  
So we know it's possible.
Here is the PREMiSe trial booklet for participating patients, where you list the endpoints.
http://www.bnac.net/wp-content/uploads/2011/05/patient-forum-5-7-2011.pdf

However, you did not achieve greater than 75% restoration of venous outflow in phase 2.  
Phase 2 was a failure.  And this fact should negate your results.  

Yet you reported on the failed treatment outcome of these patients to the world media.  You made videos, press releases and public statements based on a failed study and a poster.  

You NEVER once said the treatment didn't address their CCSVI.  You made it seem like the venoplasty was to blame for worsening MS, higher EDSS and lesions.  
But that's not true, because your ineffective venoplasty treatment left these poor people with the exact same venous insufficiency.  

You did nothing to relieve their CCSVI.